Developer docs
API playgroundTry for free, no card

Search company profiles

IVI

Full company profile

uuid000d5au

Namestring
IVI
Legal namestring
Equipo IVI, S. L.
Websiteurl
ivi.es
Company typeenum
Private
Founded yearint
1990
Descriptiontext

IVI (Instituto Valenciano de Infertilidad) is a Valencia-headquartered private fertility clinic group founded in 1990 as the first Spanish clinic dedicated entirely to assisted reproduction. The company operates a direct-to-consumer reproductive medicine platform spanning 30+ clinics across Spain and country-specific operations in nine countries (Portugal, Brazil, Chile, Germany, France, Italy, Panama, Russia, and the UK), supported by 3,000+ professionals and reported 250,000+ babies born since inception. Its clinical portfolio covers the full assisted reproduction stack — artificial insemination, IVF, ICSI, egg and sperm donation, fertility preservation (vitrification), preimplantation genetic testing (PGT/PGT-A), and specialty units in reproductive immunology, endometriosis, andrology, and reproductive surgery.

The proprietary technology layer includes IA EMBRYOSELECT (computer-vision embryo selection), Perfect Match 360° + Biometric Scan (biometric embryo-endometrium matching), and Ovarian Rejuvenation techniques (OFFA — Ovarian Fragmentation for Follicular Activation, and BMDSC — Bone Marrow-Derived Stem Cells) developed with Hospital La Fe de Valencia. The business operates what it describes as one of the world's largest egg banks, alongside dedicated donor recruitment platforms (IVI Dona, IVI Dono) and diagnostic packages. Quality credentials include ISO 9001 (since 2007), UNE 179007 and UNE 179003 certifications audited by SGS, and SEF Collaborating Center status; reported success rates run 23% above the Spanish national average per SEF data.

IVI's revenue model combines per-treatment professional service fees with consumer financing products: IVI BABY (a multi-cycle guarantee program with refund if unsuccessful), IVI Contigo (customized multi-cycle plans), and 0%-interest financing up to 24 months. Customer acquisition runs through owned digital channels (SEO, blog, podcast, localized forums in seven languages, patient portal) plus event-driven Fertility Day webinars. The group sits under the legal entity Equipo IVI, S.L., with operating subsidiaries including IVIRMA Global Education, IVIRMA Innovation, IVI Dona, and IVI Dono. In 2025, Equipo IVI executed a USD 400 million acquisition of ART Fertility Clinics, expanding into the Middle East market.

Short descriptiontext

IVI is a Valencia-headquartered private fertility clinic group founded in 1990, operating 30+ clinics across Spain and 9 countries. It offers IVF, ICSI, egg/sperm donation, fertility preservation, AI-assisted embryo selection, and ovarian rejuvenation, serving individual patients with a direct-to-consumer model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersValencia, Spain
HQ citystring
Valencia
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices28 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
assisted reproduction services, fertility treatments, in vitro fertilization, fertility preservation, reproductive medicine
Industry5 codes
1Fertility, Reproductive Endocrinology & IVF Centers
CodeHLAFAJADPrimaryYes
2Reproductive Endocrinology & Infertility (IVF/Fertility)
CodeHLAKAJACPrimaryNo
3Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
CodeHLAAALAJPrimaryNo
4Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation)
CodeHLALAHAAPrimaryNo
5Genetic, Cytogenetic & Prenatal Screening IVD
CodeHLAHAAAIPrimaryNo
NAICS code3 codes
  • Family Planning Centers621410
  • Family Planning Centers62141
  • Blood and Organ Banks621991
SIC code2 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Reproductive Medicine and Fertility Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Fertility Treatment Services
TypeProfessional Services
Description

Direct medical service fees for assisted reproduction treatments including IVF, ICSI, artificial insemination, egg donation, sperm donation, and fertility preservation. Revenue generated through clinical procedures and medical consultations.

ivi.es
2Treatment Financing
TypeSubscription Recurring
Description

IVI offers internal financing plans (IVI BABY, IVI Contigo) allowing patients to spread treatment costs over up to 24 months with 0% interest and no commissions.

ivi.es
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Pricing details4 tiers
1Free Ovarian Reserve Testing
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free AMH blood test for women aged 25-38 to assess ovarian reserve. Available year-round at all IVI clinics.

ivi.es
2IVI BABY Guarantee Plan
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Guaranteed pregnancy plan where if treatment fails, money is refunded. Provides peace of mind for patients.

ivi.es
3IVI Contigo Custom Plan
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Customized treatment plans tailored to individual patient needs and circumstances.

ivi.es
4Treatment Financing
ModelOtherBilling cadenceMonthly
Notes

Financing up to 24 months with 0% interest and no commissions (TIN 0% TAE MAX 0%). Medication financing also available.

ivi.es
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 6 records shown
1IVI BABY
Description

Guarantee program ensuring pregnancy or money back

ivi.es
+5 more records
Core offering1 text field

IVI (Instituto Valenciano de Infertilidad) operates a network of fertility clinics providing assisted reproduction treatments including artificial insemination, in vitro fertilization (IVF), ICSI, egg donation (Ovodonación), the ROPA method for female couples, and fertility preservation via egg/embryo vitrification. The clinics deliver advanced procedures supported by proprietary technologies such as AI-powered embryo selection (EMBRYOSELECT), preimplantation genetic testing (PGT-A), ovarian rejuvenation (OFFA/BMDSC), and MACS sperm selection, complemented by diagnostic packages, genetic carrier screening, non-invasive prenatal testing, and in-house financing/guarantee programs (IVI BABY, IVI Contigo).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Success rates 23% above national average (audited by SGS and presented annually to SEF)
+3 more records
Product overview1 text field

IVI (Instituto Valenciano de Infertilidad) operates as a fertility clinic network offering a comprehensive portfolio of assisted reproduction treatments. The core offerings include Inseminación Artificial (IA), Fecundación in Vitro (FIV), Método ROPA for female couples, and Ovodonación. AI-enhanced features include IA EMBRYOSELECT for computer vision-based embryo selection and Perfect Match 360° for biometric matching. Advanced services span fertility preservation (egg vitrification), preimplantation genetic testing (PGT/PGT-A), ovarian rejuvenation treatments, and reproductive surgery. Supporting services include diagnostic packages (Pack Diagnóstico), payment plans (IVI Contigo), and a money-back guarantee program (IVI BABY). The network maintains patient-facing digital tools including a mobile app and patient portal.

Product and service15 records
1Inseminación Artificial (IA) / Artificial Insemination
CategoryAssisted reproduction treatment
Description

Artificial insemination procedure using donor or partner sperm, intended for patients with viable fallopian tubes and adequate sperm parameters seeking less invasive first-line fertility treatment.

2Fecundación in Vitro (FIV) / In Vitro Fertilization (IVF)
CategoryAssisted reproduction treatment
Description

In vitro fertilization procedure combining eggs and sperm in the laboratory to create embryos for transfer, intended for couples and individuals with infertility not resolved by artificial insemination.

3Método ROPA / ROPA Method (Shared Motherhood)
CategoryAssisted reproduction treatment
Description

IVF-based shared motherhood treatment in which one female partner provides the eggs and the other partner carries the pregnancy, designed for female couples who want shared biological involvement.

4Ovodonación / Egg Donation IVF
CategoryAssisted reproduction treatment
Description

IVF treatment using eggs from carefully screened anonymous donors, intended for patients with diminished ovarian reserve, advanced maternal age, premature ovarian failure, or genetic concerns.

5Preserva de la fertilidad / Fertility Preservation
CategoryAssisted reproduction treatment
Description

Fertility preservation service through egg or embryo vitrification for women wishing to delay motherhood for personal, professional, or medical reasons (including oncology patients).

6ICSI (Microinyección espermática) / Intracytoplasmic Sperm Injection
CategoryAssisted reproduction treatment
Description

Advanced IVF technique in which a single sperm is directly injected into the egg, intended for cases of severe male-factor infertility, previous fertilization failure, or limited sperm availability.

7Vitrificación de ovocitos / Egg Vitrification
CategoryFertility preservation service
Description

Cryopreservation technique for oocytes using ultra-rapid vitrification with high post-thaw survival rates, used for fertility preservation and oocyte accumulation strategies.

8Centro de Excelencia en Rejuvenecimiento Ovárico / Ovarian Rejuvenation Center of Excellence
CategorySpecialty medical unit
Description

Specialized unit offering OFFA (Ovarian Fragmentation for Follicular Activation) and BMDSC (Bone Marrow-Derived Stem Cells) infusion techniques for patients with low ovarian reserve or premature ovarian failure.

9Test Genético Preimplantacional (PGT) / Preimplantation Genetic Testing
CategoryGenetic diagnostic test
Description

Preimplantation genetic testing of embryos for aneuploidy (PGT-A), monogenic disorders (PGT-M), or structural rearrangements (PGT-SR) prior to transfer, intended for couples with genetic risk factors or recurrent miscarriage.

10Test de Compatibilidad Genética (CARRIER Expanded) / Expanded Carrier Screening
CategoryGenetic diagnostic test
Description

Expanded genetic compatibility test screening partners for hundreds of inherited conditions before conception, intended for couples planning pregnancy or starting IVF.

11Test prenatal no invasivo (Neo 24) / Non-Invasive Prenatal Test (NIPT)
CategoryGenetic diagnostic test
Description

Non-invasive prenatal test analyzing fetal DNA from maternal blood from 10 weeks of gestation, intended for pregnant patients to screen for common chromosomal abnormalities.

12IVI BABY Guarantee Program
CategoryFinancial/guarantee program
Description

Money-back guarantee program in which patients receive a full refund of treatment costs if the treatment does not result in a successful pregnancy, intended to reduce financial risk for patients committing to IVF.

13IVI Contigo Custom Plan
CategoryFinancial/financing program
Description

Customized payment plan tailored to individual patient circumstances, allowing patients to spread fertility treatment costs over installment periods.

14Banco de Óvulos / Egg Bank
CategoryDonor gamete service
Description

One of the world's largest egg banks supplying rigorously screened anonymous donor eggs for Ovodonación treatments and recipient matching.

15Pack Diagnóstico / Diagnostic Package
CategoryDiagnostic package
Description

Initial fertility diagnostic package combining hormonal analysis, ovarian reserve testing, and a specialist consultation to assess fertility status and recommend a treatment pathway.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-04
Description

IVI participated as an industry partner in a pandemic simulation exercise organized by CEPI in collaboration with Korean parliamentary forums and government agencies. The seminar discussed how AI can transform health Official Development Assistance and strengthen Korea's role in vaccine R&D and pandemic preparedness.

2Hospital La Fe de Valencia
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2017-05-11
Description

Collaborative research partnership for ovarian rejuvenation techniques. IVI and Hospital La Fe jointly conducted studies on OFFA (Ovarian Fragmentation for Follicular Activation) and BMDSC (Bone Marrow-Derived Stem Cells) infusion techniques. The collaboration resulted in 4 successful pregnancies in patients with premature ovarian failure. Research results were presented at the 7th International IVI Congress.

ivi.es
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Eugin is a Spain-headquartered fertility clinic network operating across Europe and Latin America with a similar multi-clinic, cross-border patient model to IVI. It is one of IVI's most direct Spanish and European competitors in IVF, egg donation, and fertility preservation.

TypeDirect peer
Description

Genea is a global fertility clinic and IVF technology group headquartered in Australia with clinics in Australia, the UK, and other markets. Like IVI, it combines a multi-country clinic network with proprietary lab technology and a strong reproductive genetics offering.

TypeDirect peer
Description

Virtus Health is one of the largest fertility clinic networks globally, operating in Australia, the UK, Ireland, and Singapore. Its scale, multi-country footprint, and full-service IVF + diagnostics model make it a close international comparable to IVI.

TypeDirect peer
Description

Monash IVF is an Australian-listed fertility clinic group with clinics across Australia and Southeast Asia. It shares IVI's full-cycle reproductive medicine offering (IVF, ICSI, PGT, fertility preservation) and comparable research-driven brand positioning.

5Inception Fertility
TypeDirect peer
Description

Inception Fertility is the largest fertility services provider in the United States, operating multiple clinic brands and a frozen egg bank. Its multi-brand clinic roll-up model, donor egg assets, and tech-enabled offering mirror IVI's IVIRMA network strategy.

TypeDirect peer
Description

Reproclinic is a Barcelona-based fertility clinic specializing in IVF, egg donation, and reproductive genetics for both domestic and international patients. It is a direct Spanish competitor to IVI with overlapping services including PGT and shared motherhood treatments.

TypeBroad incumbent
Description

Dexeus Mujer is a large Barcelona-based women's health provider offering fertility, obstetrics, and gynecology services within a broader hospital-affiliated network. It competes with IVI in Catalonia and Spain but operates as part of a wider women's health portfolio rather than a pure-play fertility chain.

TypeDirect peer
Description

Bourn Hall is the UK's first IVF clinic and operates a multi-site fertility network across the UK. Like IVI, it combines a long-established clinical brand with full-service IVF, ICSI, and donor programs serving both domestic and international patients.

TypeEmerging player
Description

Progyny is a US fertility benefits and care platform that contracts with employer-sponsored patients and partner clinics. It targets the same end-patients as IVI (couples and individuals seeking IVF) but through a payer-led, technology-enabled model rather than owned clinics.

TypeOthers
Description

CooperSurgical is a global supplier of ART devices, consumables, media, and genetic testing services to IVF clinics. It is adjacent to IVI's operations as an enabling vendor across embryology, PGT, and cryopreservation rather than a direct clinic competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IVI

Reproductive Medicine and Fertility Servicesivi.es

IVI is a Valencia-headquartered private fertility clinic group founded in 1990, operating 30+ clinics across Spain and 9 countries. It offers IVF, ICSI, egg/sperm donation, fertility preservation, AI-assisted embryo selection, and ovarian rejuvenation, serving individual patients with a direct-to-consumer model.

What IVI does

IVI (Instituto Valenciano de Infertilidad) is a Valencia-headquartered private fertility clinic group founded in 1990 as the first Spanish clinic dedicated entirely to assisted reproduction. The company operates a direct-to-consumer reproductive medicine platform spanning 30+ clinics across Spain and country-specific operations in nine countries (Portugal, Brazil, Chile, Germany, France, Italy, Panama, Russia, and the UK), supported by 3,000+ professionals and reported 250,000+ babies born since inception. Its clinical portfolio covers the full assisted reproduction stack — artificial insemination, IVF, ICSI, egg and sperm donation, fertility preservation (vitrification), preimplantation genetic testing (PGT/PGT-A), and specialty units in reproductive immunology, endometriosis, andrology, and reproductive surgery.

The proprietary technology layer includes IA EMBRYOSELECT (computer-vision embryo selection), Perfect Match 360° + Biometric Scan (biometric embryo-endometrium matching), and Ovarian Rejuvenation techniques (OFFA — Ovarian Fragmentation for Follicular Activation, and BMDSC — Bone Marrow-Derived Stem Cells) developed with Hospital La Fe de Valencia. The business operates what it describes as one of the world's largest egg banks, alongside dedicated donor recruitment platforms (IVI Dona, IVI Dono) and diagnostic packages. Quality credentials include ISO 9001 (since 2007), UNE 179007 and UNE 179003 certifications audited by SGS, and SEF Collaborating Center status; reported success rates run 23% above the Spanish national average per SEF data.

IVI's revenue model combines per-treatment professional service fees with consumer financing products: IVI BABY (a multi-cycle guarantee program with refund if unsuccessful), IVI Contigo (customized multi-cycle plans), and 0%-interest financing up to 24 months. Customer acquisition runs through owned digital channels (SEO, blog, podcast, localized forums in seven languages, patient portal) plus event-driven Fertility Day webinars. The group sits under the legal entity Equipo IVI, S.L., with operating subsidiaries including IVIRMA Global Education, IVIRMA Innovation, IVI Dona, and IVI Dono. In 2025, Equipo IVI executed a USD 400 million acquisition of ART Fertility Clinics, expanding into the Middle East market.

IVI firmographics

Firmographics
Name
IVI
Legal name
Equipo IVI, S. L.
Website
https://ivi.es
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
IVI is a Valencia-headquartered private fertility clinic group founded in 1990, operating 30+ clinics across Spain and 9 countries. It offers IVF, ICSI, egg/sperm donation, fertility preservation, AI-assisted embryo selection, and ovarian rejuvenation, serving individual patients with a direct-to-consumer model.
Ownership category
akta.pro rank

IVI industry classification

Industry
Product category
Reproductive Medicine and Fertility Services
NAICS
Family Planning Centers (621410), Family Planning Centers (62141), Blood and Organ Banks (621991)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
akta.pro secondary industries
Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)

Keywords

  • Assisted reproduction services
  • Fertility treatments
  • In vitro fertilization
  • Fertility preservation
  • Reproductive medicine

Where IVI is headquartered

Location

Headquarters

HQ city
Valencia
HQ country
Spain
HQ region
Europe

Offices28 records

Markets served

IVI business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Fertility Treatment Services: Direct medical service fees for assisted reproduction treatments including IVF, ICSI, artificial insemination, egg donation, sperm donation, and fertility preservation. Revenue generated through clinical procedures and medical consultations.
  2. Treatment Financing: IVI offers internal financing plans (IVI BABY, IVI Contigo) allowing patients to spread treatment costs over up to 24 months with 0% interest and no commissions.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goFree Ovarian Reserve Testing
SubscriptionMulti-year contractIVI BABY Guarantee Plan
SubscriptionMulti-year contractIVI Contigo Custom Plan
OtherMonthlyTreatment Financing

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

IVI product offering

Product offering

Core offering

IVI (Instituto Valenciano de Infertilidad) operates a network of fertility clinics providing assisted reproduction treatments including artificial insemination, in vitro fertilization (IVF), ICSI, egg donation (Ovodonación), the ROPA method for female couples, and fertility preservation via egg/embryo vitrification. The clinics deliver advanced procedures supported by proprietary technologies such as AI-powered embryo selection (EMBRYOSELECT), preimplantation genetic testing (PGT-A), ovarian rejuvenation (OFFA/BMDSC), and MACS sperm selection, complemented by diagnostic packages, genetic carrier screening, non-invasive prenatal testing, and in-house financing/guarantee programs (IVI BABY, IVI Contigo).

Product overview

IVI (Instituto Valenciano de Infertilidad) operates as a fertility clinic network offering a comprehensive portfolio of assisted reproduction treatments. The core offerings include Inseminación Artificial (IA), Fecundación in Vitro (FIV), Método ROPA for female couples, and Ovodonación. AI-enhanced features include IA EMBRYOSELECT for computer vision-based embryo selection and Perfect Match 360° for biometric matching. Advanced services span fertility preservation (egg vitrification), preimplantation genetic testing (PGT/PGT-A), ovarian rejuvenation treatments, and reproductive surgery. Supporting services include diagnostic packages (Pack Diagnóstico), payment plans (IVI Contigo), and a money-back guarantee program (IVI BABY). The network maintains patient-facing digital tools including a mobile app and patient portal.

Differentiator

Problem solved

Functional benefit

Brands

  • IVI BABY: Guarantee program ensuring pregnancy or money back
  • IVI Contigo
  • IVI Dona
  • IVI Dono
  • Preserva
  • FIV Genetic

Products and services

  • Inseminación Artificial (IA) / Artificial Insemination Artificial insemination procedure using donor or partner sperm, intended for patients with viable fallopian tubes and adequate sperm parameters seeking less invasive first-line fertility treatment.
  • Fecundación in Vitro (FIV) / In Vitro Fertilization (IVF) In vitro fertilization procedure combining eggs and sperm in the laboratory to create embryos for transfer, intended for couples and individuals with infertility not resolved by artificial insemination.
  • Método ROPA / ROPA Method (Shared Motherhood) IVF-based shared motherhood treatment in which one female partner provides the eggs and the other partner carries the pregnancy, designed for female couples who want shared biological involvement.
  • Ovodonación / Egg Donation IVF IVF treatment using eggs from carefully screened anonymous donors, intended for patients with diminished ovarian reserve, advanced maternal age, premature ovarian failure, or genetic concerns.
  • Preserva de la fertilidad / Fertility Preservation Fertility preservation service through egg or embryo vitrification for women wishing to delay motherhood for personal, professional, or medical reasons (including oncology patients).
  • ICSI (Microinyección espermática) / Intracytoplasmic Sperm Injection Advanced IVF technique in which a single sperm is directly injected into the egg, intended for cases of severe male-factor infertility, previous fertilization failure, or limited sperm availability.
  • Vitrificación de ovocitos / Egg Vitrification Cryopreservation technique for oocytes using ultra-rapid vitrification with high post-thaw survival rates, used for fertility preservation and oocyte accumulation strategies.
  • Centro de Excelencia en Rejuvenecimiento Ovárico / Ovarian Rejuvenation Center of Excellence Specialized unit offering OFFA (Ovarian Fragmentation for Follicular Activation) and BMDSC (Bone Marrow-Derived Stem Cells) infusion techniques for patients with low ovarian reserve or premature ovarian failure.
  • Test Genético Preimplantacional (PGT) / Preimplantation Genetic Testing Preimplantation genetic testing of embryos for aneuploidy (PGT-A), monogenic disorders (PGT-M), or structural rearrangements (PGT-SR) prior to transfer, intended for couples with genetic risk factors or recurrent miscarriage.
  • Test de Compatibilidad Genética (CARRIER Expanded) / Expanded Carrier Screening Expanded genetic compatibility test screening partners for hundreds of inherited conditions before conception, intended for couples planning pregnancy or starting IVF.
  • Test prenatal no invasivo (Neo 24) / Non-Invasive Prenatal Test (NIPT) Non-invasive prenatal test analyzing fetal DNA from maternal blood from 10 weeks of gestation, intended for pregnant patients to screen for common chromosomal abnormalities.
  • IVI BABY Guarantee Program Money-back guarantee program in which patients receive a full refund of treatment costs if the treatment does not result in a successful pregnancy, intended to reduce financial risk for patients committing to IVF.
  • IVI Contigo Custom Plan Customized payment plan tailored to individual patient circumstances, allowing patients to spread fertility treatment costs over installment periods.
  • Banco de Óvulos / Egg Bank One of the world's largest egg banks supplying rigorously screened anonymous donor eggs for Ovodonación treatments and recipient matching.
  • Pack Diagnóstico / Diagnostic Package Initial fertility diagnostic package combining hormonal analysis, ovarian reserve testing, and a specialist consultation to assess fertility status and recommend a treatment pathway.

Quantifiable outcome

  • Success rates 23% above national average (audited by SGS and presented annually to SEF)
  • +3 more outcomes

Companies that use IVI

Customer profile

Named customers4 records

Segments6 records

Ideal customer profiles6 records

IVI technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature8 records

IVI partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor and core.

  • CEPI (Coalition for Epidemic Preparedness Innovations)minorStrategic or Co-development Partner · 4 February 2026IVI participated as an industry partner in a pandemic simulation exercise organized by CEPI in collaboration with Korean parliamentary forums and government agencies. The seminar discussed how AI can transform health Official Development Assistance and strengthen Korea's role in vaccine R&D and pandemic preparedness.
  • Hospital La Fe de ValenciacoreStrategic or Co-development Partner · 11 May 2017Collaborative research partnership for ovarian rejuvenation techniques. IVI and Hospital La Fe jointly conducted studies on OFFA (Ovarian Fragmentation for Follicular Activation) and BMDSC (Bone Marrow-Derived Stem Cells) infusion techniques. The collaboration resulted in 4 successful pregnancies in patients with premature ovarian failure. Research results were presented at the 7th International IVI Congress.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

IVI competitors and assessment

Company assessment

Direct peers

  • Eugin: Eugin is a Spain-headquartered fertility clinic network operating across Europe and Latin America with a similar multi-clinic, cross-border patient model to IVI. It is one of IVI's most direct Spanish and European competitors in IVF, egg donation, and fertility preservation.
  • Genea: Genea is a global fertility clinic and IVF technology group headquartered in Australia with clinics in Australia, the UK, and other markets. Like IVI, it combines a multi-country clinic network with proprietary lab technology and a strong reproductive genetics offering.
  • Virtus Health: Virtus Health is one of the largest fertility clinic networks globally, operating in Australia, the UK, Ireland, and Singapore. Its scale, multi-country footprint, and full-service IVF + diagnostics model make it a close international comparable to IVI.
  • Monash IVF: Monash IVF is an Australian-listed fertility clinic group with clinics across Australia and Southeast Asia. It shares IVI's full-cycle reproductive medicine offering (IVF, ICSI, PGT, fertility preservation) and comparable research-driven brand positioning.
  • Inception Fertility: Inception Fertility is the largest fertility services provider in the United States, operating multiple clinic brands and a frozen egg bank. Its multi-brand clinic roll-up model, donor egg assets, and tech-enabled offering mirror IVI's IVIRMA network strategy.
  • Reproclinic: Reproclinic is a Barcelona-based fertility clinic specializing in IVF, egg donation, and reproductive genetics for both domestic and international patients. It is a direct Spanish competitor to IVI with overlapping services including PGT and shared motherhood treatments.
  • Bourn Hall Clinic: Bourn Hall is the UK's first IVF clinic and operates a multi-site fertility network across the UK. Like IVI, it combines a long-established clinical brand with full-service IVF, ICSI, and donor programs serving both domestic and international patients.

Broad incumbents

  • Dexeus Mujer: Dexeus Mujer is a large Barcelona-based women's health provider offering fertility, obstetrics, and gynecology services within a broader hospital-affiliated network. It competes with IVI in Catalonia and Spain but operates as part of a wider women's health portfolio rather than a pure-play fertility chain.

Emerging players

  • Progyny: Progyny is a US fertility benefits and care platform that contracts with employer-sponsored patients and partner clinics. It targets the same end-patients as IVI (couples and individuals seeking IVF) but through a payer-led, technology-enabled model rather than owned clinics.

Others

  • CooperSurgical: CooperSurgical is a global supplier of ART devices, consumables, media, and genetic testing services to IVF clinics. It is adjacent to IVI's operations as an enabling vendor across embryology, PGT, and cryopreservation rather than a direct clinic competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

IVI social profiles

Digital presence

IVI compliance and trust

Trust signal

Compliance2 records

IVI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IVI leadership team

Management profile

Number of profiles

Profiles4 records

IVI subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

IVI funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IVI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IVI

What does IVI do?

IVI (Instituto Valenciano de Infertilidad) operates a network of fertility clinics providing assisted reproduction treatments including artificial insemination, in vitro fertilization (IVF), ICSI, egg donation (Ovodonación), the ROPA method for female couples, and fertility preservation via egg/embryo vitrification. The clinics deliver advanced procedures supported by proprietary technologies such as AI-powered embryo selection (EMBRYOSELECT), preimplantation genetic testing (PGT-A), ovarian rejuvenation (OFFA/BMDSC), and MACS sperm selection, complemented by diagnostic packages, genetic carrier screening, non-invasive prenatal testing, and in-house financing/guarantee programs (IVI BABY, IVI Contigo).

Is IVI a public or private company?

IVI is a private company. It is classified as unknown and is currently operating.

When was IVI founded?

IVI was founded in 1990. It employs 1,001 to 5,000 people.

Where is IVI based?

IVI is headquartered in Valencia, Spain, in the Europe region.

How does IVI make money?

Two revenue lines are on record. Fertility Treatment Services are the primary driver. The others are treatment Financing.

Who are IVI's main competitors?

Direct peers on record are Eugin, Genea, Virtus Health, Monash IVF, Inception Fertility, Reproclinic and Bourn Hall Clinic. Dexeus Mujer is listed as a broad incumbent. Progyny is listed as an emerging player. CooperSurgical is listed as an others.

Does IVI have an API?

No public API is recorded for IVI.

What industry is IVI in?

IVI's product category is Reproductive Medicine and Fertility Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAKAJAC, Reproductive Endocrinology & Infertility (IVF/Fertility). Its NAICS code is 621410 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EleconomistaLa genética permite alcanzar tasas de gestación de hasta el 70% mediante estrategias reproductivas personalizadasIVI's reproductive genetics unit reports pregnancy rates up to 70% through personalized genetic testing. The program covers preconception, preimplantation, and prenatal phases, with PGT-A for advanced maternal age and Neo24 for non-invasive fetal DNA. The approach targets chromosomal aneuploidies and monogenic disorders.EleconomistaLa monitorización personalizada reduce al mínimo el riesgo de complicaciones durante la estimulación ováricaIVI Alicante's doctor Rebeca Jiménez says severe ovarian hyperstimulation is under 1% with current protocols, while mild cases occur in under 10% and resolve on their own. Personalized monitoring via estradiol levels and tailored dosing for high-risk patients minimizes complications.EleconomistaLa probabilidad de obtener un embrión cromosómicamente sano cae del 20% con 40 años al 5% con 43IVI data shows euploidy rates for IVF embryos fall from 20% at age 40 to 5% at 43. PGT-A testing allows avoiding failed transfers and can reach 90-95% cumulative success after three euploid transfers. IVI recommends ovodonation for women over 43.EleconomistaLos óvulos vitrificados no tienen caducidad biológica y superan el 95% de supervivencia tras la descongelaciónDr. Manuel M\u00fanoz, director of IVI Alicante, explained that vitrified eggs have no biological expiration because their metabolic activity nearly stops, so a frozen egg ages according to its biological age regardless of storage time. Ovocyte survival after thawing exceeds 95%, though it drops in women over 38, making freezing age the key clinical factor. Spanish law sets no maximum, with a clinical consensus of about 51 years.EleconomistaMás de la mitad de las mujeres de 40 a 42 años logra ser madre en IVI con sus propios óvulosLa clínica IVI ha reportado que en sus tratamientos de reproducción asistida, más del 50% de las mujeres que inician el proceso tienen entre 40 y 42 años. La tasa de embarazo varía del 50% con óvulos propios al 60% con óvulos donados en esa franja de edad, aumentando a partir de los 42 años.BdoalamriMiddle East M&A Outlook 2026: Key Trends & Sector InsightsMiddle East M&A activity in H2 2025 shifted toward larger, more strategic transactions as deal volume declined to 44 from 48 in H1 while total disclosed deal value increased to USD 5.8 billion from USD 4.7 billion, reflecting investor preference for conviction-led platform investments over broad-based activity. The UAE anchored regional deal activity with major transactions including SOFAZ's USD 500 million solar portfolio acquisition and International Holding Company PJSC and Alpha Dhabi Holding's USD 436 million stake increase in NMDC Group, while private equity re-engaged through transactions such as TPG Capital's USD 157 million Halalah Trading investment and Equipo IVI's USD 400 million ART Fertility Clinics acquisition. IPO markets across the GCC remained active but Saudi Arabia faced liquidity pressures in Q4 2025 with weaker retail participation and cancelled offerings including Rawabi Marketing International and Lavenco, signaling a more cautious 2026 outlook.AOL.comInside the operations at a fertility clinicThe article provides a visual overview of operations at fertility clinics in Spain, highlighting the preparation of sperm and egg samples for fertilization processes. It notes that lenient laws have enabled clinics like Eugin and IVI to serve a diverse range of patients, including couples and single women, with over 5,000 annual visitors to one such facility.